Su DG - Search Results

1

Surgical Outcomes and Utilization of Laparoscopic Versus Robotic Techniques for Elective Colectomy in Asian American and Native Hawaiian-Pacific Islanders (AAPI) Diagnosed With Colon Cancer.

Ahuja V, Murthy SS, Leeds IL, Paredes LG, Su DG, Tsutsumi A, Perkal MF, King JT Jr. Ahuja V, et al. Among authors: su dg. J Surg Res. 2024 Oct;302:40-46. doi: 10.1016/j.jss.2024.07.007. Epub 2024 Jul 30. J Surg Res. 2024. PMID: 39083904

2

Outcomes Following Implementation of an Electronic Model for Perioperative Hematologic Consultation.

Su DG, Rehman S, Wang K, Deng Y, Rose MG, Dosani T, Kunstman JW. Su DG, et al. J Surg Res. 2024 Sep;301:10-17. doi: 10.1016/j.jss.2024.04.033. Epub 2024 Jun 20. J Surg Res. 2024. PMID: 38905768

3

When Benchmarks Fail Us: A Case Study in Cytoreductive Surgery.

Bansal VV, Witmer HDD, Childers CP, Su DG, Turaga KK; RVU Writing Group; PSM Consortium Group. Bansal VV, et al. Among authors: su dg. Ann Surg Oncol. 2025 Jan;32(1):19-23. doi: 10.1245/s10434-024-16191-y. Epub 2024 Oct 26. Ann Surg Oncol. 2025. PMID: 39460818

4

Educational Review: Clinical Application of Immune Checkpoint Blockade for the Treatment of Melanoma.

Su D, Kluger H, Olino K. Su D, et al. Ann Surg Oncol. 2024 Mar;31(3):1865-1879. doi: 10.1245/s10434-023-14587-w. Epub 2023 Nov 21. Ann Surg Oncol. 2024. PMID: 37989956 Review.

5

Melanocortin 1 receptor (MC1R) expression as a marker of progression in melanoma.

Su D, Djureinovic D, Schoenfeld D, Marquez-Nostra B, Olino K, Jilaveanu L, Kluger H. Su D, et al. Res Sq [Preprint]. 2023 Sep 19:rs.3.rs-3314825. doi: 10.21203/rs.3.rs-3314825/v1. Res Sq. 2023. Update in: JCO Precis Oncol. 2024 Apr;8:e2300702. doi: 10.1200/PO.23.00702 PMID: 37790306 Free PMC article. Updated. Preprint.

6

Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma.

Su DG, Schoenfeld DA, Ibrahim W, Cabrejo R, Djureinovic D, Baumann R, Rimm DL, Khan SA, Halaban R, Kluger HM, Olino K, Galan A, Clune J. Su DG, et al. J Immunother Cancer. 2024 Mar 21;12(3):e008646. doi: 10.1136/jitc-2023-008646. J Immunother Cancer. 2024. PMID: 38519058 Free PMC article.

7

Melanocortin-1 Receptor Expression as a Marker of Progression in Melanoma.

Su DG, Djureinovic D, Schoenfeld D, Marquez-Nostra B, Olino K, Jilaveanu L, Kluger H. Su DG, et al. JCO Precis Oncol. 2024 Apr;8:e2300702. doi: 10.1200/PO.23.00702. JCO Precis Oncol. 2024. PMID: 38662983

8

CheckMate-915: does adjuvant CTLA-4 blockade play a role in resected melanoma?

Su D, Kluger H, Weiss SA. Su D, et al. Ann Transl Med. 2023 Aug 30;11(10):370. doi: 10.21037/atm-23-754. Epub 2023 Mar 6. Ann Transl Med. 2023. PMID: 37675335 Free PMC article. No abstract available.

9

Multi-Institutional Study Evaluating the Role of Circulating Tumor DNA in the Management of Appendiceal Cancers.

Belmont E, Bansal VV, Yousef MMG, Zeineddine MA, Su D, Dhiman A, Liao CY, Polite B, Eng OS, Fournier KF, White MG, Turaga KK, Shen JP, Shergill A. Belmont E, et al. JCO Precis Oncol. 2024 May;8:e2300531. doi: 10.1200/PO.23.00531. JCO Precis Oncol. 2024. PMID: 38723230

10

Mutational Features and Tumor Microenvironment Alterations in High-Grade Appendiceal Cancers Treated With Iterative Hyperthermic Intraperitoneal Chemotherapy.

Su DG, Dhiman A, Bansal VV, Zha Y, Shergill A, Polite B, Alpert L, Turaga KK, Eng OS. Su DG, et al. JCO Precis Oncol. 2024 Sep;8:e2400149. doi: 10.1200/PO.24.00149. JCO Precis Oncol. 2024. PMID: 39259912

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters